What IV vial strengths are commercially available for labetalol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Labetalol Vial Strengths

Labetalol for intravenous use is commercially available as 5 mg/mL concentration in either 20-mL vials (100 mg total) or 40-mL vials (200 mg total). 1

Standard Vial Configurations

  • 20-mL vials contain 100 mg of labetalol HCl (5 mg/mL concentration) 1
  • 40-mL vials contain 200 mg of labetalol HCl (5 mg/mL concentration) 1

Preparation for Continuous Infusion

When preparing labetalol for continuous IV infusion, the FDA label describes two standard methods using these vial sizes:

  • Method 1: Add contents of either two 20-mL vials (40 mL total) or one 40-mL vial to 160 mL of IV fluid to create 200 mL solution containing 200 mg labetalol (1 mg/mL final concentration) 1

  • Method 2: Add contents of either two 20-mL vials (40 mL total) or one 40-mL vial to 250 mL of IV fluid to create solution containing 200 mg labetalol (approximately 2 mg/3 mL final concentration) 1

Clinical Context

  • The 5 mg/mL concentration allows for precise bolus dosing, starting with 20 mg (4 mL) administered over 2 minutes, with subsequent doses of 40 mg (8 mL) or 80 mg (16 mL) at 10-minute intervals up to a maximum cumulative dose of 300 mg 1

  • For continuous infusion, the diluted solution (1 mg/mL) should be administered at 2 mL/min to deliver 2 mg/min 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.